Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

The Rationale, Design and Baseline Data of FLOW, a Kidney Outcomes Trial with Once-Weekly Semaglutide in People with Type 2 Diabetes and Chronic Kidney Disease.

Kenneth W. Mahaffey,Katherine R. Tuttle,Mustafa Arici,Florian M. M. Baeres,George Bakris,David M. Charytan,David Z. Cherney,Gil Chernin,Ricardo Correa-Rotter,Janusz Gumprecht,Thomas Idorn,Giuseppe Pugliese,Ida Kirstine Bull Rasmussen,Soren Rasmussen,Peter Rossing,Ekaterina Sokareva,Johannes F. E. Mann,Vlado Perkovic,Richard Pratley

EUROPEAN HEART JOURNAL（2024）

Cited 106|Views9

Key words

Semaglutide,Cardiovascular outcomes,Type 2 diabetes,Chronic kidney disease

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined